Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Influenza

  Free Subscription


Articles published in J Infect Dis

Retrieve available abstracts of 95 articles:
HTML format
Text format



Single Articles


    June 2017
  1. PAULES CI, Lakdawala S, McAuliffe JM, Paskel M, et al
    An HA stem antibody MEDI8852 prevents and controls disease and limits transmission of pandemic influenza viruses.
    J Infect Dis. 2017 Jun 17. doi: 10.1093.
    PubMed     Text format     Abstract available


  2. CHUNG JR, Flannery B, Zimmerman RK, Nowalk MP, et al
    Prior season vaccination and risk of influenza during the 2014-2015 season in the U.S.
    J Infect Dis. 2017 Jun 13. doi: 10.1093.
    PubMed     Text format    


    May 2017
  3. RANDOLPH AG, Yip WK, Allen EK, Rosenberger CM, et al
    Evaluation of IFITM3 rs12252 Association with Severe Pediatric Influenza Infection.
    J Infect Dis. 2017 May 20. doi: 10.1093.
    PubMed     Text format     Abstract available


  4. LEE N, Cao B, Ke C, Lu H, et al
    IFITM3, TLR3, and CD55 Genes SNPs and Cumulative Ge-netic Risks for Severe Outcomes in Chinese Patients with H7N9 / H1N1pdm09 Influenza.
    J Infect Dis. 2017 May 16. doi: 10.1093.
    PubMed     Text format     Abstract available


  5. HIROSE R, Nakaya T, Naito Y, Daidoji T, et al
    Mechanism of human influenza virus RNA persistence and virion survival in feces: mucus protects virions from acid and digestive juices.
    J Infect Dis. 2017 May 11. doi: 10.1093.
    PubMed     Text format     Abstract available


  6. AGUAYO-HIRALDO PI, Arasaratnam RJ, Tzannou I, Kuvalekar M, et al
    Characterizing the cellular immune response to Parainfluenza virus 3.
    J Infect Dis. 2017 May 2. doi: 10.1093.
    PubMed     Text format     Abstract available


  7. WAGHMARE A, Englund JA, Boeckh M
    Parainfluenza Virus 3-specific T Cells: Opportunity for Intervention?
    J Infect Dis. 2017 May 2. doi: 10.1093.
    PubMed     Text format    


  8. SCHLABERG R, Queen K, Simmon K, Tardif K, et al
    Viral Pathogen Detection by Metagenomics and Pan-Viral Group Polymerase Chain Reaction in Children With Pneumonia Lacking Identifiable Etiology.
    J Infect Dis. 2017;215:1407-1415.
    PubMed     Text format     Abstract available


    April 2017
  9. THWAITES RS, Ito K, Chingono JMS, Coates M, et al
    Nasosorption as a Minimally Invasive Sampling Procedure: Mucosal Viral Load and Inflammation in Primary RSV Bronchiolitis.
    J Infect Dis. 2017;215:1240-1244.
    PubMed     Text format     Abstract available


  10. HUANG X, Mengersen K, Milinovich G, Hu W, et al
    Effect of weather variability on seasonal influenza among different age groups in Queensland, Australia: A Bayesian spatiotemporal analysis.
    J Infect Dis. 2017 Apr 12. doi: 10.1093.
    PubMed     Text format     Abstract available


    March 2017
  11. MOHN KG, Zhou F, Brokstad KA, Sridhar S, et al
    Live attenuated influenza vaccination boosts durable cross-reactive and protection-associated T-cells in children.
    J Infect Dis. 2017 Mar 27. doi: 10.1093.
    PubMed     Text format     Abstract available


  12. PETRIE JG, Monto AS
    Untangling the Effects of Prior Vaccination on Subsequent Influenza Vaccine Effectiveness.
    J Infect Dis. 2017;215:841-843.
    PubMed     Text format    


  13. MARTINEZ-BAZ I, Casado I, Navascues A, Diaz-Gonzalez J, et al
    Effect of Repeated Vaccination With the Same Vaccine Component Against 2009 Pandemic Influenza A(H1N1) Virus.
    J Infect Dis. 2017;215:847-855.
    PubMed     Text format     Abstract available


  14. SHAY DK, Chillarige Y, Kelman J, Forshee RA, et al
    Comparative Effectiveness of High-Dose Versus Standard-Dose Influenza Vaccines Among US Medicare Beneficiaries in Preventing Postinfluenza Deaths During 2012-2013 and 2013-2014.
    J Infect Dis. 2017 Mar 2. doi: 10.1093.
    PubMed     Text format     Abstract available


  15. MONTO AS
    Moving Toward Improved Influenza Vaccines.
    J Infect Dis. 2017 Mar 2. doi: 10.1093.
    PubMed     Text format    


  16. CASERTA MT, Qiu X, Tesini B, Wang L, et al
    Development of a Global Respiratory Severity Score for Respiratory Syncytial Virus Infection in Infants.
    J Infect Dis. 2017;215:750-756.
    PubMed     Text format     Abstract available


    February 2017
  17. LIU L, Nachbagauer R, Zhu L, Huang Y, et al
    Induction of Broadly Cross-Reactive Stalk-Specific Antibody Responses to Influenza Group 1 and Group 2 Hemagglutinins by Natural H7N9 Virus Infection in Humans.
    J Infect Dis. 2017;215:518-528.
    PubMed     Text format     Abstract available


  18. SKOWRONSKI DM, Chambers C, De Serres G, Sabaiduc S, et al
    Serial vaccination and the antigenic distance hypothesis: effects on influenza vaccine effectiveness during A(H3N2) epidemics in Canada, 2010-11 to 2014-15.
    J Infect Dis. 2017 Feb 9. doi: 10.1093.
    PubMed     Text format    


  19. BOECKH M, Stevens-Ayers T, Travi G, Huang ML, et al
    Bronchoalveolar Lavage DNA Quantification in Cytomegalovirus Pneumonia after Hematopoietic Cell Transplantation.
    J Infect Dis. 2017 Feb 9. doi: 10.1093.
    PubMed     Text format    


  20. PETRIE JG, Monto AS
    Untangling the Effects of Prior Vaccination on Subsequent Influenza Vaccine Effectiveness.
    J Infect Dis. 2017 Feb 7. doi: 10.1093.
    PubMed     Text format    


  21. MARTINEZ-BAZ I, Casado I, Navascues A, Diaz-Gonzalez J, et al
    Effect of Repeated Vaccination With the Same Vaccine Component Against Influenza A(H1N1)pdm09.
    J Infect Dis. 2017 Feb 7. doi: 10.1093.
    PubMed     Text format    


    January 2017
  22. ARNOTT A, Carville K, Franklin L, Sullivan SG, et al
    Consecutive Influenza Infections in Both Adults and Children.
    J Infect Dis. 2017 Jan 18. doi: 10.1093.
    PubMed     Text format    


  23. HEIKKINEN T, Ojala E, Waris M
    Clinical and Socioeconomic Burden of Respiratory Syncytial Virus Infection in Children.
    J Infect Dis. 2017;215:17-23.
    PubMed     Text format     Abstract available


    December 2016
  24. EWING A, Lee EC, Viboud C, Bansal S, et al
    Contact, travel, and transmission: The impact of winter holidays on influenza dynamics in the United States.
    J Infect Dis. 2016 Dec 28. pii: jiw642. doi: 10.1093.
    PubMed     Text format     Abstract available


  25. HADLER JL
    Christmas-New Year influenza lull: not too late for vaccination.
    J Infect Dis. 2016 Dec 28. pii: jiw643. doi: 10.1093.
    PubMed     Text format    


  26. JEGASKANDA S, Co MD, Cruz J, Subbarao K, et al
    Human seasonal influenza A viruses induce H7N9-cross-reactive antibody-dependent cellular cytotoxicity (ADCC) antibodies that are directed towards the nucleoprotein.
    J Infect Dis. 2016 Dec 23. pii: jiw629. doi: 10.1093.
    PubMed     Text format     Abstract available


  27. TRIEU MC, Zhou F, Lartey S, Jul-Larsen A, et al
    Long-term maintenance of the influenza-specific cross-reactive memory CD4+ T-cell responses following repeated annual influenza vaccination.
    J Infect Dis. 2016 Dec 22. pii: jiw619. doi: 10.1093.
    PubMed     Text format     Abstract available


  28. PETRIE JG, Parkhouse K, Ohmit SE, Malosh RE, et al
    Antibodies Against the Current Influenza A(H1N1) Vaccine Strain Do Not Protect Some Individuals From Infection With Contemporary Circulating Influenza A(H1N1) Virus Strains.
    J Infect Dis. 2016;214:1947-1951.
    PubMed     Text format     Abstract available


  29. SHIMIZU K, Wulandari L, Poetranto ED, Setyoningrum RA, et al
    Seroevidence for a High Prevalence of Subclinical Infection With Avian Influenza A(H5N1) Virus Among Workers in a Live-Poultry Market in Indonesia.
    J Infect Dis. 2016;214:1929-1936.
    PubMed     Text format     Abstract available


  30. FEDSON DS
    Statins, Influenza Vaccination and Influenza.
    J Infect Dis. 2016.
    PubMed     Text format    


  31. FEDSON DS
    Statins, Influenza Vaccination and Influenza.
    J Infect Dis. 2016 Dec 7. doi: 10.1093.
    PubMed     Text format    


    October 2016
  32. LIU WJ, Tan S, Zhao M, Quan C, et al
    Cross-Immunities against Avian Influenza H7N9 Virus in the Healthy Population Affected by Antigenicity-Dependent Substitutions.
    J Infect Dis. 2016.
    PubMed     Text format     Abstract available


  33. MORI I
    Vaccination Effectively Prevents Central Nervous System Invasion by Influenza A(H5N1) Virus Through the Olfactory Pathway: A Proposed Mechanism of Neuroprotection.
    J Infect Dis. 2016.
    PubMed     Text format    



  34. Live attenuated influenza vaccine in children induces B-cell responses in tonsils.
    J Infect Dis. 2016.
    PubMed     Text format    


    September 2016
  35. LANGLEY JM, Aggarwal N, Toma A, Halperin SA, et al
    A randomized, controlled, observer-blind Phase I study of the safety and immunogenicity of a Respiratory Syncytial Virus vaccine with or without alum adjuvant.
    J Infect Dis. 2016.
    PubMed     Text format     Abstract available


  36. LE GARS M, Kay AW, Bayless NL, Aziz N, et al
    Increased Pro-Inflammatory Responses of Monocytes and Plasmacytoid Dendritic Cells to Influenza A Virus Infection During Pregnancy.
    J Infect Dis. 2016.
    PubMed     Text format     Abstract available


  37. YU KO, Randolph AG, Agan AA, Yip WK, et al
    Staphylococcus aureus alpha-toxin Response Distinguishes Respiratory Virus-MRSA Co-infection in Children.
    J Infect Dis. 2016.
    PubMed     Text format     Abstract available


  38. MADAN A, Segall N, Ferguson M, Frenette L, et al
    Immunogenicity and safety of an AS03-adjuvanted H7N9 pandemic influenza vaccine in a randomized trial in healthy adults.
    J Infect Dis. 2016.
    PubMed     Text format     Abstract available


  39. ETTENSOHN DB, Frampton MW, Nichols JE, Roberts NJ Jr, et al
    HUMAN ALVEOLAR MACROPHAGES MAY NOT BE SUSCEPTIBLE TO DIRECT INFECTION BY A HUMAN INFLUENZA VIRUS.
    J Infect Dis. 2016.
    PubMed     Text format     Abstract available


    August 2016
  40. REBER AJ, Kim JH, Coleman LA, Spencer SM, et al
    Seasonal Influenza Vaccination of Children Induces Humoral and Cell-Mediated Immunity Beyond the Current Season: Cross-reactivity with Past and Future Strains.
    J Infect Dis. 2016.
    PubMed     Text format     Abstract available


  41. EDWARDS KM, Keitel WA
    Challenges Remain for Influenza Vaccination of Children.
    J Infect Dis. 2016.
    PubMed     Text format    


  42. KIM JH, Mishina M, Chung JR, Cole KS, et al
    Cell-mediated immunity against antigenically drifted influenza A(H3N2) viruses in children during a vaccine mismatch season.
    J Infect Dis. 2016.
    PubMed     Text format     Abstract available


  43. VALKENBURG SA, Zhang Y, Chan KY, Leung K, et al
    Pre-existing ADCC antibody responses are stable longitudinally and cross-reactive responses are not boosted by recent influenza exposure.
    J Infect Dis. 2016.
    PubMed     Text format     Abstract available


    July 2016
  44. MCLEAN HQ, Chow BD, VanWormer JJ, King JP, et al
    The Effect of Statin Use on Influenza Vaccine Effectiveness.
    J Infect Dis. 2016.
    PubMed     Text format     Abstract available


  45. HOFT DF, Lottenbach K, Goll JB, Hill H, et al
    Priming Vaccination with H5 Hemagglutinin Antigen Significantly Increases the Duration of T cell Responses Induced by a Heterologous H5 Booster Vaccination.
    J Infect Dis. 2016.
    PubMed     Text format     Abstract available


    June 2016
  46. JEGASKANDA S, Luke C, Hickman HD, Sangster MY, et al
    The generation and protective ability of influenza-specific antibody-dependent cellular cytotoxicity in humans elicited by vaccination, natural infection or experimental challenge.
    J Infect Dis. 2016.
    PubMed     Text format     Abstract available


    May 2016
  47. MOHN KG, Brokstad KA, Pathirana RD, Bredholt G, et al
    Live attenuated influenza vaccination in children induces B-cell responses in tonsils.
    J Infect Dis. 2016.
    PubMed     Text format     Abstract available


  48. SCHOTSAERT M, Garcia-Sastre A
    A high resolution look at influenza antigenic drift.
    J Infect Dis. 2016.
    PubMed     Text format    


  49. FLANNERY B, Zimmerman RK, Gubareva LV, Garten RJ, et al
    Enhanced genetic characterization of influenza A(H3N2) viruses and vaccine effectiveness by genetic group, 2014-2015.
    J Infect Dis. 2016.
    PubMed     Text format     Abstract available


    April 2016
  50. MOST J, Weiss G
    Consecutive Infections With Influenza A and B Virus in Children During the 2014-2015 Seasonal Influenza Epidemic.
    J Infect Dis. 2016.
    PubMed     Text format     Abstract available


  51. NEUZIL KM
    The Art and Science of Delivering Influenza Vaccines.
    J Infect Dis. 2016.
    PubMed     Text format    


  52. PETRIE JG, Ohmit SE, Truscon R, Johnson E, et al
    Modest Waning of Influenza Vaccine Efficacy and Antibody Titers During the 2007-2008 Influenza Season.
    J Infect Dis. 2016.
    PubMed     Text format     Abstract available


    March 2016
  53. TCHERNIUK S, Cenac N, Comte M, Frouard J, et al
    Formyl peptide receptor 2 plays a deleterious role during influenza A virus infections.
    J Infect Dis. 2016.
    PubMed     Text format     Abstract available


  54. CRABTREE JN, He W, Guan W, Flage M, et al
    Autoimmune variant PTPN22 C1858T is associated with impaired responses to influenza virus vaccination.
    J Infect Dis. 2016.
    PubMed     Text format     Abstract available


  55. SKJERVEN HO, Megremis S, Papadopoulos NG, Mowinckel P, et al
    Virus Type and Genomic Load in Acute Bronchiolitis: Severity and Treatment Response With Inhaled Adrenaline.
    J Infect Dis. 2016;213:915-21.
    PubMed     Text format     Abstract available


  56. VIBOUD C, Simonsen L, Fuentes R, Flores J, et al
    Global Mortality Impact of the 1957-1959 Influenza Pandemic.
    J Infect Dis. 2016;213:738-45.
    PubMed     Text format     Abstract available


    February 2016
  57. SELF WH, Williams DJ, Zhu Y, Ampofo K, et al
    Respiratory Viral Detection in Children and Adults: Comparing Asymptomatic Controls and Patients With Community-Acquired Pneumonia.
    J Infect Dis. 2016;213:584-91.
    PubMed     Text format     Abstract available


  58. ZURLI V, Gallotta M, Taccone M, Chiarot E, et al
    Positive contribution of adjuvanted influenza vaccines on the resolution of bacterial superinfections.
    J Infect Dis. 2016.
    PubMed     Text format     Abstract available


  59. MASCITELLI L, Goldstein MR
    How regulatory T cells induction by statin drugs may impair influenza vaccine immunogenicity and effectiveness.
    J Infect Dis. 2016.
    PubMed     Text format    


  60. OBOHO I, Reed C, Gargiullo P, Leon M, et al
    The benefit of early influenza antiviral treatment of pregnant women hospitalized with laboratory-confirmed influenza.
    J Infect Dis. 2016.
    PubMed     Text format     Abstract available


  61. TITA AT, Andrews WW
    Influenza Vaccination and Antiviral Therapy in Pregnant Women.
    J Infect Dis. 2016.
    PubMed     Text format    


    January 2016
  62. PENNINGTON SH, Thompson AL, Wright AK, Ferreira DM, et al
    Oral typhoid vaccination with Ty21a generates Ty21a-responsive and heterologous influenza-responsive CD4+ and CD8+ T-cells at the human intestinal mucosa.
    J Infect Dis. 2016.
    PubMed     Text format     Abstract available


  63. PAVIA AT
    Influenza Vaccine Effectiveness: Mysteries, Enigmas, and a Few Clues.
    J Infect Dis. 2016.
    PubMed     Text format    


  64. GAGLANI M, Pruszynski J, Murthy K, Clipper L, et al
    Influenza Vaccine Effectiveness Against 2009 Pandemic Influenza A(H1N1) Virus Differed by Vaccine Type During 2013-2014 in the United States.
    J Infect Dis. 2016.
    PubMed     Text format     Abstract available


    December 2015
  65. SOBHANIE M, Matsuoka Y, Jegaskanda S, Fitzgerald T, et al
    Evaluation of the Safety and Immunogenicity of a Candidate Pandemic Live Attenuated Influenza Vaccine (pLAIV) Against Influenza A(H7N9).
    J Infect Dis. 2015.
    PubMed     Text format     Abstract available


  66. L'HUILLIER AG, Abed Y, Petty TJ, Cordey S, et al
    E119D Neuraminidase Mutation Conferring Pan-Resistance to Neuraminidase Inhibitors in an A(H1N1)pdm09 Isolate From a Stem-Cell Transplant Recipient.
    J Infect Dis. 2015;212:1726-34.
    PubMed     Text format     Abstract available


  67. BAGGA B, Cehelsky JE, Vaishnaw A, Wilkinson T, et al
    Effect of Preexisting Serum and Mucosal Antibody on Experimental Respiratory Syncytial Virus (RSV) Challenge and Infection of Adults.
    J Infect Dis. 2015;212:1719-25.
    PubMed     Text format     Abstract available


  68. MUNYWOKI PK, Koech DC, Agoti CN, Bett A, et al
    Frequent Asymptomatic Respiratory Syncytial Virus Infections During an Epidemic in a Rural Kenyan Household Cohort.
    J Infect Dis. 2015;212:1711-8.
    PubMed     Text format     Abstract available


    November 2015
  69. SCHULERT GS, Zhang M, Fall N, Husami A, et al
    Whole exome sequencing reveals mutations in hemophagocytic lymphohistiocytosis and macrophage activation syndrome linked genes in fatal cases of H1N1 influenza.
    J Infect Dis. 2015.
    PubMed     Text format     Abstract available


  70. OHMIT SE, Petrie JG, Malosh RE, Johnson E, et al
    Substantial Influenza Vaccine Effectiveness Observed in Households with Children in a Season in which A (pH1N1) Predominated (2013-2014).
    J Infect Dis. 2015.
    PubMed     Text format     Abstract available


  71. ARRIOLA CS, Chaves SS
    Reply to Chughtai et al.
    J Infect Dis. 2015;212:1684-5.
    PubMed     Text format    


  72. CHUGHTAI AA, Rahman B, MacIntyre CR
    Commentary On Arriola et al. Antivirals and Effect Modification in Influenza Studies.
    J Infect Dis. 2015;212:1683-4.
    PubMed     Text format    


    October 2015
  73. BLACK S, Nicolay U, Del Giudice G, Rappuoli R, et al
    Influence of Statins on Influenza Vaccine Response in Elderly Individuals.
    J Infect Dis. 2015.
    PubMed     Text format     Abstract available


  74. OMER SB, Phadke VK, Bednarczyk RA, Chamberlain AT, et al
    Impact of Statins on Influenza Vaccine Effectiveness Against Medically Attended Acute Respiratory Illness.
    J Infect Dis. 2015.
    PubMed     Text format     Abstract available


  75. ATMAR RL, Keitel WA
    Influenza Vaccination of Patients Receiving Statins: Where Do We Go From Here?
    J Infect Dis. 2015.
    PubMed     Text format    


  76. LEE N, Chan MC, Lui GC, Li R, et al
    High Viral Load and Respiratory Failure in Adults Hospitalized for Respiratory Syncytial Virus Infections.
    J Infect Dis. 2015;212:1237-40.
    PubMed     Text format     Abstract available


    September 2015
  77. DAVEY RT JR, Markowitz N, Beigel J, Wentworth D, et al
    INSIGHT FLU005: An Anti-Influenza Hyperimmune Intravenous Immunoglobulin Pilot Study.
    J Infect Dis. 2015.
    PubMed     Text format     Abstract available


  78. GESSNER BD
    Severe Acute Respiratory Illness in Sub-Saharan Africa.
    J Infect Dis. 2015;212:843-4.
    PubMed     Text format    


    August 2015
  79. GLENN GM, Fries LF, Thomas DN, Smith G, et al
    A randomized, blinded, controlled, dose-ranging study of a respiratory syncytial virus recombinant fusion (F) nanoparticle vaccine in healthy women of childbearing age.
    J Infect Dis. 2015.
    PubMed     Text format     Abstract available


  80. NELSON MI, Wentworth DE, Das SR, Sreevatsan S, et al
    Evolutionary dynamics of influenza A viruses in US exhibition swine.
    J Infect Dis. 2015.
    PubMed     Text format     Abstract available


  81. BARANOVICH T, Bahl J
    Influenza A Virus diversity and transmission in exhibition swine.
    J Infect Dis. 2015.
    PubMed     Text format    


  82. WANG W, Facundo EA, Chen Q, Anderson CM, et al
    Sera from middle-aged adults vaccinated annually with seasonal influenza vaccines cross-neutralize some potential pandemic influenza viruses.
    J Infect Dis. 2015.
    PubMed     Text format     Abstract available


    July 2015
  83. SUAREZ NM, Bunsow E, Falsey AR, Walsh EE, et al
    Superiority of transcriptional profiling over procalcitonin for distinguishing bacterial from viral lower respiratory tract infections in hospitalized adults.
    J Infect Dis. 2015;212:213-22.
    PubMed     Text format     Abstract available


  84. TSALIK EL, McClain M, Zaas AK
    Moving toward prime time: host signatures for diagnosis of respiratory infections.
    J Infect Dis. 2015;212:173-5.
    PubMed     Text format    


  85. PLOTKIN SA
    Increasing Complexity of Vaccine Development.
    J Infect Dis. 2015;212 Suppl 1:S12-6.
    PubMed     Text format     Abstract available


  86. VAN DER VRIES E, Ip DK, Cowling BJ, Zhang JD, et al
    Outcomes and Susceptibility to Neuraminidase Inhibitors in Individuals Infected with Different Influenza B Lineages: the Influenza Resistance Information Study.
    J Infect Dis. 2015.
    PubMed     Text format     Abstract available


  87. FONVILLE JM, Fraaij PL, de Mutsert G, Wilks SH, et al
    Antigenic maps of influenza A/H3N2 virus produced with human antisera obtained after primary infection.
    J Infect Dis. 2015.
    PubMed     Text format     Abstract available


    June 2015
  88. URAKI R, Piao Z, Akeda Y, Iwatsuki-Horimoto K, et al
    A bivalent vaccine based on a PB2-knockout influenza virus protects mice from secondary pneumococcal pneumonia.
    J Infect Dis. 2015.
    PubMed     Text format     Abstract available


  89. NUNES MC, Cutland CL, Dighero B, Bate J, et al
    Kinetics of hemagglutination-inhibition antibodies following maternal influenza vaccination in HIV-infected and HIV-uninfected women-infant dyads.
    J Infect Dis. 2015.
    PubMed     Text format     Abstract available


  90. LEENTJENS J, Kox M, Stokman R, Gerretsen J, et al
    BCG-vaccination enhances immunogenicity of subsequent influenza vaccination in healthy volunteers: a randomized placebo-controlled pilot study.
    J Infect Dis. 2015.
    PubMed     Text format     Abstract available


  91. INAGAKI K, Song MS, Crumpton JC, DeBeauchamp J, et al
    Determination of Influenza Virus Infectivity and Correlation to Diagnostic Assays in Ferret Model.
    J Infect Dis. 2015.
    PubMed     Text format     Abstract available


  92. CAO W, Mishina M, Ranjan P, De La Cruz JA, et al
    A newly emerged swine origin A(H3N2)v influenza virus dampens host antiviral immunity but induces potent inflammasome activation.
    J Infect Dis. 2015.
    PubMed     Text format     Abstract available


    May 2015
  93. WONG G, Qiu X, Ebihara H, Feldmann H, et al
    Characterization of a Bivalent Vaccine Capable of Inducing Protection Against Both Ebola and Cross-clade H5N1 Influenza in Mice.
    J Infect Dis. 2015.
    PubMed     Text format     Abstract available


  94. PETRIE JG, Ohmit SE, Johnson E, Truscon R, et al
    Persistence of Antibodies to Influenza Hemagglutinin and Neuraminidase Following One or Two Years of Influenza Vaccination.
    J Infect Dis. 2015.
    PubMed     Text format     Abstract available


  95. HASEGAWA K, Jartti T, Mansbach JM, Laham FR, et al
    Respiratory syncytial virus genomic load and disease severity among children hospitalized with bronchiolitis: multicenter cohort studies in the United States and Finland.
    J Infect Dis. 2015;211:1550-9.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Influenza is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: